Global Cerebral Aneurysm Treatment Market, By Type (Surgery, Medication), Condition (Unruptured Aneurysm, Ruptured Aneurysm), Drug Type (Calcium Channel Blockers, Antiepileptics, Antihypertensives, Analgesics, Antiemetics, Antacids, Stool Softeners), Route of Administration (Oral, Injection, Transdermal), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Cerebral Aneurysm Treatment Market
The cerebral aneurysm treatment market is expected to witness market growth at a rate of 6.00% in the forecast period of 2021 to 2028. Data Bridge Market Research report on cerebral aneurysm treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of brain aneurysm is escalating the growth of cerebral aneurysm treatment market.
A cerebral or intracranial aneurysm is defined as an abnormal focal dilation seen in the artery of the brain that may result from a weakening of the inner muscular layer of a blood vessel wall. A "blister-like" dilation is initially developed that later turns into thin and may rupture with no warning. There is a bleeding in the space around the brain as a result which is called subarachnoid hemorrhage (SAH) that may cause stroke, coma or even death.
The increase in the number of patients suffering from cerebrovascular disorder across the globe, acts as one of the major factors driving the growth of cerebral aneurysm treatment market. The rise in the number of patients suffering from high blood pressure and trauma to blood vessels and growing adoption of unhealthy lifestyle patterns such as smoking causing cerebral aneurysm accelerate the market growth. The increased in adoption of medical therapies for treatment of un-ruptured intracranial aneurysms and the rise in the number of innovations in neurodegenerative disease drug discovery further influence the market. Additionally, increase in the number of cigarette smokers responsible for brain cancer, research and development, improving healthcare infrastructure and surge in healthcare expenditure positively affect the cerebral aneurysm treatment market. Furthermore, innovations in drugs and treatment options extend profitable opportunities to the market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the treatment of cerebral aneurysm is expected to obstruct the market growth. Lack of effective and specific treatment is projected to challenge the cerebral aneurysm treatment market in the forecast period of 2021-2028.
This cerebral aneurysm treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info cerebral aneurysm treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Cerebral Aneurysm Treatment Market Scope and Market Size
The cerebral aneurysm treatment market is segmented on the basis of type, condition, drug type, route of administration and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the cerebral aneurysm treatment market is segmented into surgery and medication.
- On the basis of condition, the cerebral aneurysm treatment market is segmented into unruptured aneurysm and ruptured aneurysm.
- On the basis of drug type, the cerebral aneurysm treatment market is segmented into calcium channel blockers, antiepileptics, antihypertensives, analgesics, antiemetics, antacids and stool softeners. Calcium channel blockers are further segmented into Nimodipine. Antiepileptics are further segmented into fosphenytoin (Rx). Antihypertensives are further segmented into labetalol (Rx) and hydralazine (Rx). Analgesics are further segmented into morphine (Rx). Antiemetics are further segmented into prochlorperazine (Rx). Antacids are further segmented into ranitidine. Stool softeners are further segmented into docusate (OTC).
- On the basis of route of administration, the cerebral aneurysm treatment market is segmented into oral, injection and transdermal.
- On the basis of distribution channel, the cerebral aneurysm treatment market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.
Global Cerebral Aneurysm Treatment Market Country Level Analysis
The cerebral aneurysm treatment market is analyzed and market size information is provided by country, type, condition, drug type, route of administration and distribution channel as referenced above.
The countries covered in the global cerebral aneurysm treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the cerebral aneurysm treatment market due to the presence of well-established healthcare facilities, high incidence of hypertension and stroke and rise in the prevalence of cerebral aneurysm within the region. Asia-Pacific is expected to witness highest growth during the forecast period of 2021 to 2028 because of the improvement in the quality of diagnosis, rising incidence of hypertension, increasing patient affordability and large population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The cerebral aneurysm treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period of 2010-2019.
Competitive Landscape and Cerebral Aneurysm Treatment Market Share Analysis
The cerebral aneurysm treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related cerebral aneurysm treatment market.
The major players covered in the cerebral aneurysm treatment market report are Biogen, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp., Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Corporation., UCB S.A., Acadia Pharmaceuticals Inc., H. Lundbeck A/S, and Mitsubishi Tanabe Pharma Corporation. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-